Millennium Management
RUBY

Millennium Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

Millennium Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-169,571
Closed -$29K – 7327
2022
Q4 		$29K Sell
169,571
-55,193
-25% -$15.1K ﹤0.01% 5959
2022
Q3 		$98K Sell
224,764
-688,193
-75% -$516K ﹤0.01% 5978
2022
Q2 		$777K Buy
912,957
+391,481
+75% +$657K ﹤0.01% 4603
2022
Q1 		$2.87M Buy
521,476
+469,027
+894% +$2.98M ﹤0.01% 3538
2021
Q4 		$508K Buy
52,449
+32,311
+160% +$448K ﹤0.01% 5030
2021
Q3 		$360K Sell
20,138
-84,755
-81% -$1.84M ﹤0.01% 5672
2021
Q2 		$2.56M Buy
104,893
+94,154
+877% +$2.36M ﹤0.01% 3648
2021
Q1 		$285K Sell
10,739
-30,240
-74% -$442K ﹤0.01% 5247
2020
Q4 		$311K Sell
40,979
-32,164
-44% -$191K ﹤0.01% 4523
2020
Q3 		$366 Buy
+73,143
New +$387K ﹤0.01% 3740
2020
Q2 		– Sell
-18,155
Closed -$81K – 4758
2020
Q1 		$81K Sell
18,155
-226,500
-93% -$1.68M ﹤0.01% 3594
2019
Q4 		$2.32M Buy
244,655
+184,836
+309% +$1.79M ﹤0.01% 2516
2019
Q3 		$469K Sell
59,819
-30,984
-34% -$361K ﹤0.01% 3307
2019
Q2 		$1.43M Buy
+90,803
New +$1.47M ﹤0.01% 2602

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Millennium Management's RUBY Position: Q1 2023 in Review

Millennium Management sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 169,571 shares — an estimated $29K sold.

Millennium Management first reported a position in RUBY in Q2 2019 and held it in 14 quarters. The position peaked at $2.87M in Q1 2022. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Millennium Management reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 169,571 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $29K.
  • Millennium Management first reported a position in Rubius Therapeutics, Inc in Q2 2019 and held it in 14 quarters.
  • Millennium Management's Rubius Therapeutics, Inc position peaked at $2.87M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.